GEMTESA Trademark

Trademark Overview

On Thursday, November 1, 2018, a trademark application was filed for GEMTESA with the United States Patent and Trademark Office. The USPTO has given the GEMTESA trademark a serial number of 79246577. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, December 22, 2025. This trademark is owned by Urovant Sciences GmbH. The GEMTESA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical and biological preparations for the treatment of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical preparations for human use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical preparations for human use for the treatment of urological, urinary tract systems, and reproductive organ diseases and disorders; Biological and pharmaceutical preparations for medical and therapeutic use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; Biological and pharmaceutical preparations for medical and therapeutic use for the treatment of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical preparations for treatment of the bladder an...
gemtesa

General Information

Serial Number79246577
Word MarkGEMTESA
Filing DateThursday, November 1, 2018
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, December 22, 2025
Registration Number5876586
Registration DateTuesday, October 8, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements

Goods and ServicesPharmaceutical and biological preparations for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical and biological preparations for the treatment of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical preparations for human use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical preparations for human use for the treatment of urological, urinary tract systems, and reproductive organ diseases and disorders; Biological and pharmaceutical preparations for medical and therapeutic use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; Biological and pharmaceutical preparations for medical and therapeutic use for the treatment of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical preparations for treatment of the bladder and urinary pathologies; Pharmaceutical preparations for treatment of a hyperactive bladder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 30, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUrovant Sciences GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressZug CH-6300
CH
Party NameUrovant Sciences GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressCH
Party NameUrovant Sciences GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Thursday, November 29, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 30, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 4, 2018APPLICATION FILING RECEIPT MAILED
Wednesday, December 12, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 31, 2019ASSIGNED TO EXAMINER
Friday, February 1, 2019NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 4, 2019NON-FINAL ACTION WRITTEN
Tuesday, February 5, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 13, 2019REFUSAL PROCESSED BY MPU
Wednesday, February 13, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, March 2, 2019REFUSAL PROCESSED BY IB
Friday, April 12, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 12, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 31, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, June 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, January 8, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, February 3, 2020FINAL DISPOSITION PROCESSED
Monday, February 3, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 21, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, March 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 29, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 25, 2022NEW REPRESENTATIVE AT IB RECEIVED
Saturday, March 18, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, February 23, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, April 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 8, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, April 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 12, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Friday, April 12, 2024WITHDRAWAL OF ATTORNEY GRANTED
Thursday, October 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 3, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, October 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 8, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, March 13, 2025NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 28, 2025TEAS SECTION 71 & 15 RECEIVED
Monday, December 1, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 22, 2025REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Monday, December 22, 2025NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

Related Keywords

gemtesa pharmaceutical preparations disorders organ diseases systems reproductive urological urinary tract